Biosurgery Market Astonishing Growth with Top Influencing Key players
Biosurgery products are used in numerous surgical procedures
to minimize intra- and post-operative complications. The increasing geriatric
population, a growing number of surgical procedures, rising occurrences of
trauma and sports-related injuries are the major factors driving the growth of
the global biosurgery market.
Additionally, increasing R&D spending and aggressive
strategies adopted by the top players, such as new product launches, are
contributing to the growth of the biosurgery
market. For instance, in March 2015, Kuros Biosurgery announced the grant
of a US patent for its synthetic hydrogel technology which is a combination of
bioactive and biomaterial products such as sealants and orthobiologics.The high
costs associated with surgeries, stringent regulatory environment for product
approval, and increasing popularity of minimally invasive surgeries are likely
to hinder market growth during the forecast period.
Key Players
Some of the key players in the global biosurgery market are
Baxter International, Inc., B. Braun
Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding
B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences
Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC,
Sanofi, Pfizer Inc., Stryker Corporation, Cryolife, Inc., and Kuros Biosciences
Ltd.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6246
Segmentation
The global biosurgery market has been segmented on the basis
of product, source, and application.
On the basis of product, the market has been classified as
bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical
sealants and adhesives, adhesion barriers, and staple-line reinforcement
agents. The bone-graft substitutes segment has been further divided into
demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins,
and other bone-graft substitutes. The hemostatic agents segment has been
further divided into thrombin-based hemostatic agents, oxidized regenerated
cellulose-based hemostatic agents, and combination hemostatic agents. The soft-tissue
attachments segment has been classified as synthetic meshes and biological
meshes. The surgical sealants and adhesives segment has been divided into
natural and synthetic sealants and adhesives. The natural sealants sub-segment
has been segmented into fibrin sealants, collagen-based sealants, gelatin-based
sealants, albumin-based sealants, and other natural sealants. The synthetic
sealants segment has been divided into peg hydrogels, cyanoacrylate-based
sealants and adhesives, urethane-based sealants and adhesives, and others.
Furthermore, the adhesion barriers segment has been sub-segmented into
synthetic and natural adhesion barriers. The synthetic adhesion barriers
segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers.
The natural adhesion barriers segment includes collagen- and fibrin-based
adhesion barriers.
The market, by source, has been segmented into biological
and natural products. On basis of application, the market has been divided into
neurological surgery, general surgery, cardiovascular surgery, orthopedic
surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and
urology surgery.
Regional Analysis
The market in the Americas is expected to dominate the
global biosurgery market during the forecast period owing to the increasing
prevalence of chronic diseases along with the growing geriatric population,
rising occurrences of injuries, and well-established healthcare sector in the
region. The European market is expected to be the second-largest due to government
funding and support of the healthcare sector, coupled with increasing research
and development. Moreover, the market in Asia-Pacific is anticipated to be the
fastest-growing during the forecast period owing to technological development,
an increasing number of advanced surgeries in emerging economies, and favorable
government initiatives for healthcare facilities. The market in the Middle East
& Africa is likely to account for the smallest share of the global
biosurgery market. The market growth in this region can be attributed to
increasing healthcare expenditure and low manufacturing costs of
pharmaceuticals.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/biosurgery-market-6246
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment